Phase I/II Thymus Transplantation With Immunosuppression #950

NCT00579527 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sumitomo Pharma Switzerland GmbH

Collaborators